Literature DB >> 20975872

Association of lipid metabolism with ovarian cancer.

M Tania1, M A Khan, Y Song.   

Abstract

Defects in lipid metabolism have been found to be linked to several diseases, among which atherosclerosis, hypertension, obesity, and diabetes are the most important. Although cancer is chiefly a genetic disease, dietary lipid intake and metabolism are related to some cancer risks, including the risk for ovarian cancer. Higher intake of dietary lipids, systemic lipid metabolism malfunction, and abnormal serum lipid levels are somehow related to ovarian cancer. Overexpression of some lipid metabolic enzymes are also found in ovarian cancer. In this review article, we summarize the relationships between lipid intake, lipid metabolism, and ovarian cancer.

Entities:  

Keywords:  Ovarian cancer; cholesterol; fatty acid synthase; lipids; metabolism; phospholipids

Year:  2010        PMID: 20975872      PMCID: PMC2949373          DOI: 10.3747/co.v17i5.668

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  57 in total

1.  Lysophosphatidic acid induction of vascular endothelial growth factor expression in human ovarian cancer cells.

Authors:  Y L Hu; M K Tee; E J Goetzl; N Auersperg; G B Mills; N Ferrara; R B Jaffe
Journal:  J Natl Cancer Inst       Date:  2001-05-16       Impact factor: 13.506

Review 2.  Dietary lipids and cancer.

Authors:  S Granados; J L Quiles; A Gil; M C Ramírez-Tortosa
Journal:  Nutr Hosp       Date:  2006-05       Impact factor: 1.057

Review 3.  Fatty acid synthase and cancer: new application of an old pathway.

Authors:  Francis P Kuhajda
Journal:  Cancer Res       Date:  2006-06-15       Impact factor: 12.701

Review 4.  Lipid second messengers.

Authors:  M Liscovitch; L C Cantley
Journal:  Cell       Date:  1994-05-06       Impact factor: 41.582

5.  Inhibition of N-methyl-N-nitrosourea- and 7,12-dimethylbenz[a] anthracene-induced rat mammary tumorigenesis by dietary cholesterol is independent of Ha-Ras mutations.

Authors:  A El-Sohemy; M C Archer
Journal:  Carcinogenesis       Date:  2000-04       Impact factor: 4.944

6.  Prospective study of serum micronutrients and ovarian cancer.

Authors:  K J Helzlsouer; A J Alberg; E P Norkus; J S Morris; S C Hoffman; G W Comstock
Journal:  J Natl Cancer Inst       Date:  1996-01-03       Impact factor: 13.506

7.  Dietary fat intake and ovarian cancer in a cohort of US women.

Authors:  Elizabeth R Bertone; Bernard A Rosner; David J Hunter; Meir J Stampfer; Frank E Speizer; Graham A Colditz; Walter C Willett; Susan E Hankinson
Journal:  Am J Epidemiol       Date:  2002-07-01       Impact factor: 4.897

8.  Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells.

Authors:  Javier A Menendez; Luciano Vellon; Inderjit Mehmi; Bharvi P Oza; Santiago Ropero; Ramon Colomer; Ruth Lupu
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-02       Impact factor: 11.205

Review 9.  [Lysophosphatidic acid as a potential target for treatment and molecular diagnosis of epithelial ovarian cancers].

Authors:  János Tanyi; János Rigó
Journal:  Orv Hetil       Date:  2009-06-14       Impact factor: 0.540

10.  Aberrations in normal systemic lipid metabolism in ovarian cancer patients.

Authors:  C Gercel-Taylor; D L Doering; F B Kraemer; D D Taylor
Journal:  Gynecol Oncol       Date:  1996-01       Impact factor: 5.482

View more
  35 in total

1.  Pathway-Structured Predictive Model for Cancer Survival Prediction: A Two-Stage Approach.

Authors:  Xinyan Zhang; Yan Li; Tomi Akinyemiju; Akinyemi I Ojesina; Phillip Buckhaults; Nianjun Liu; Bo Xu; Nengjun Yi
Journal:  Genetics       Date:  2016-11-09       Impact factor: 4.562

2.  Abnormalities in Plasma Phospholipid Fatty Acid Profiles of Patients with Hepatocellular Carcinoma.

Authors:  Jian-Feng Qiu; Ke-Lin Zhang; Xiao-Jing Zhang; Yuan-Jia Hu; Peng Li; Chang-Zhen Shang; Jian-Bo Wan
Journal:  Lipids       Date:  2015-08-21       Impact factor: 1.880

Review 3.  Checkpoint inhibitors in immunotherapy of ovarian cancer.

Authors:  Dong-hui Wang; Liang Guo; Xiao-hua Wu
Journal:  Tumour Biol       Date:  2014-11-20

Review 4.  EMMPRIN in gynecologic cancers: pathologic and therapeutic aspects.

Authors:  Dan-tong Liu
Journal:  Tumour Biol       Date:  2015-05-14

5.  Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.

Authors:  Oana A Zeleznik; Clary B Clish; Peter Kraft; Julian Avila-Pacheco; A Heather Eliassen; Shelley S Tworoger
Journal:  J Natl Cancer Inst       Date:  2020-06-01       Impact factor: 13.506

6.  Expression and effects of modulation of the K2P potassium channels TREK-1 (KCNK2) and TREK-2 (KCNK10) in the normal human ovary and epithelial ovarian cancer.

Authors:  A Innamaa; L Jackson; V Asher; G van Schalkwyk; A Warren; A Keightley; D Hay; A Bali; H Sowter; R Khan
Journal:  Clin Transl Oncol       Date:  2013-03-12       Impact factor: 3.405

7.  Polarity switching mass spectrometry imaging of healthy and cancerous hen ovarian tissue sections by infrared matrix-assisted laser desorption electrospray ionization (IR-MALDESI).

Authors:  Milad Nazari; David C Muddiman
Journal:  Analyst       Date:  2016-01-21       Impact factor: 4.616

Review 8.  Role of epithelial to mesenchymal transition proteins in gynecological cancers: pathological and therapeutic perspectives.

Authors:  Xiao-Mei Zhou; Hai Zhang; Xia Han
Journal:  Tumour Biol       Date:  2014-08-29

9.  A Prospective Analysis of Circulating Plasma Metabolites Associated with Ovarian Cancer Risk.

Authors:  Clary B Clish; Shelley S Tworoger; Oana A Zeleznik; A Heather Eliassen; Peter Kraft; Elizabeth M Poole; Bernard A Rosner; Sarah Jeanfavre; Amy A Deik; Kevin Bullock; Daniel S Hitchcock; Julian Avila-Pacheco
Journal:  Cancer Res       Date:  2020-01-22       Impact factor: 12.701

10.  Relationship between polymorphisms of the lipid metabolism-related gene PLA2G16 and risk of colorectal cancer in the Chinese population.

Authors:  Xiao-Nv Xie; Jing Yu; Li-Hua Zhang; Zhi-Ying Luo; Dong-Sheng Ouyang; Ling-Jie Zheng; Chun-Yang Wang; Li Yang; Ling Chen; Zhi-Rong Tan
Journal:  Funct Integr Genomics       Date:  2018-10-20       Impact factor: 3.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.